News & Events
MARCH 20, 2020
GammaTile: New Approach For The Treatment Of Brain Tumors. Watch here
MARCH 9, 2020
GT Medical Technologies Named as "Fierce 15" Company of 2019 by FierceMedTech. Read more
JANUARY 27, 2020
GT Medical Technologies Announces FDA Clearance of Expanded Indication for GammaTile Therapy.
Read more
JANUARY 22, 2020
Vidant, ECU Brody School of Medicine successfully perform first-in-state GammaTile procedure.
JANUARY 1, 2020
2019 Year In Review by President & CEO Matt Likens. Read here
DECEMBER 27, 2019
Menorah Medical Center performs new brain surgery in Kansas. Watch here
NOVEMBER 10, 2019
What's Happening in Health: Liz Bonis is joined by a team to talk about brain tumor surgery. Watch here
OCTOBER 21, 2019
Battling Brain Tumors With Time-Released Radiation. Watch here
OCTOBER 11, 2019
Fighting Tumors With Brain Implants. El Camino Doctors Turn To Radiation "Tiles" In The Fight Against Recurring Brain Tumors. Read here
OCTOBER 1, 2019
El Camino Health First on West Coast to Offer New Targeted Therapy for Recurrent Brain Tumors.
SEPTEMBER 18, 2019
Arizona: The New Frontier in Technology and Health Care. Read here
AUGUST 26, 2019
GT Medical Technologies, Inc. to Be Honored With an AZBio Fast Lane Award. Read here
AUGUST 20, 2019
Mayfield Brain and Spine neurosurgeon using new radiation therapy in Ohio. View video
AUGUST 15, 2019
GT Medical Technologies announces completion of first case in Arizona using GammaTile Therapy.
AUGUST 14, 2019
New therapy to slow down brain tumors forever changes Arizona woman's life. View video
GT Medical Technologies announces the presentation of data demonstrating the safety profile of GammaTile Therapy for various brain tumors.
JUNE 17, 2019
JUNE 11, 2019
GT Medical Technologies is a Tempe-based company that has created a new way to target brain tumors, like the type that took the late Senator John McCain’s life. Watch the interview with Dr. David Brachman, Co-Founder and Chief Technology Officer of GT Medical Technologies, to learn more. View video
Surgically Targeted Radiation Therapy: A Prospective Trial in 79 Recurrent, Previously Irradiated Intracranial Neoplasms. A presentation at the 2019 American Association of Neurological Surgeons Annual Scientific Meeting.
APRIL 15, 2019
GT Medical Technologies co-founder to receive prestigious Rosenblum-Mahaley Clinical Research Award at 2019 American Association of Neurological Surgeons annual scientific meeting.
APRIL 11, 2019
Tempe-based medical tech startup improving recovery for brain tumor patients.
APRIL 8, 2019
Doctors at the University of Minnesota are the first in the country to use a breakthrough brain cancer treatment.
FEBRUARY 14, 2019
University of Minnesota is the first in the U.S. to offer GammaTile Therapy, a new targeted therapy for recurrent brain tumors.
FEBRUARY 14, 2019
GT Medical Technologies, Inc. announces $10 million financing to support launch of targeted therapy for patients with recurrent brain tumors.
JANUARY 31, 2019
JANUARY 3, 2019
GT announces clinical trial results and accompanying publication in the Journal of Neurosurgery (JNS).
MARCH 21, 2020
The Lifestyle List: GammaTile, A New Approach For The Treatment Of Brain Tumors. Watch here
MARCH 20, 2020
GammaTile: New Approach For The Treatment Of Brain Tumors. Watch here
MARCH 12, 2020
GammaTile: A Game-Changing Procedure. Watch here
MARCH 9, 2020
GT Medical Technologies Named as "Fierce 15" Company of 2019 by FierceMedTech. Read more
JANUARY 27, 2020
GT Medical Technologies Announces FDA Clearance of Expanded Indication for GammaTile Therapy.
Read more
JANUARY 22, 2020
Vidant, ECU Brody School of Medicine successfully perform first-in-state GammaTile procedure.
JANUARY 1, 2020
2019 Year In Review by President & CEO Matt Likens. Read here
DECEMBER 27, 2019
Menorah Medical Center performs new brain surgery in Kansas. Watch here
NOVEMBER 10, 2019
What's Happening in Health: Liz Bonis is joined by a team to talk about brain tumor surgery. Watch here
OCTOBER 21, 2019
Battling Brain Tumors With Time-Released Radiation. Watch here
OCTOBER 11, 2019
Fighting Tumors With Brain Implants. El Camino Doctors Turn To Radiation "Tiles" In The Fight Against Recurring Brain Tumors. Read here
OCTOBER 1, 2019
El Camino Health First on West Coast to Offer New Targeted Therapy for Recurrent Brain Tumors.
SEPTEMBER 18, 2019
Arizona: The New Frontier in Technology and Health Care. Read here
AUGUST 26, 2019
GT Medical Technologies, Inc. to Be Honored With an AZBio Fast Lane Award. Read here
AUGUST 20, 2019
Mayfield Brain and Spine neurosurgeon using new radiation therapy in Ohio. View video
AUGUST 15, 2019
GT Medical Technologies announces completion of first case in Arizona using GammaTile Therapy.
AUGUST 14, 2019
New therapy to slow down brain tumors forever changes Arizona woman's life. View video
GT Medical Technologies announces the presentation of data demonstrating the safety profile of GammaTile Therapy for various brain tumors.
JUNE 17, 2019
JUNE 11, 2019
GT Medical Technologies is a Tempe-based company that has created a new way to target brain tumors, like the type that took the late Senator John McCain’s life. Watch the interview with Dr. David Brachman, Co-Founder and Chief Technology Officer of GT Medical Technologies, to learn more. View video
Surgically Targeted Radiation Therapy: A Prospective Trial in 79 Recurrent, Previously Irradiated Intracranial Neoplasms. A presentation at the 2019 American Association of Neurological Surgeons Annual Scientific Meeting.
APRIL 15, 2019
GT Medical Technologies co-founder to receive prestigious Rosenblum-Mahaley Clinical Research Award at 2019 American Association of Neurological Surgeons annual scientific meeting.
APRIL 11, 2019
Tempe-based medical tech startup improving recovery for brain tumor patients.
APRIL 8, 2019
Doctors at the University of Minnesota are the first in the country to use a breakthrough brain cancer treatment.
FEBRUARY 14, 2019
University of Minnesota is the first in the U.S. to offer GammaTile Therapy, a new targeted therapy for recurrent brain tumors.
FEBRUARY 14, 2019
GT Medical Technologies, Inc. announces $10 million financing to support launch of targeted therapy for patients with recurrent brain tumors.
JANUARY 31, 2019
JANUARY 3, 2019
GT announces clinical trial results and accompanying publication in the Journal of Neurosurgery (JNS).